Skip to main content
Top
Published in: BMC Neurology 1/2024

Open Access 01-12-2024 | Alzheimer's Disease | Research

The SNP rs6859 in NECTIN2 gene is associated with underlying heterogeneous trajectories of cognitive changes in older adults

Authors: Aravind Lathika Rajendrakumar, Konstantin G. Arbeev, Olivia Bagley, Anatoliy I. Yashin, Svetlana Ukraintseva, for the Alzheimer’s Disease Neuroimaging Initiative

Published in: BMC Neurology | Issue 1/2024

Login to get access

Abstract

Background

Functional decline associated with dementia, including in Alzheimer’s disease (AD), is not uniform across individuals, and respective heterogeneity is not yet fully explained. Such heterogeneity may in part be related to genetic variability among individuals. In this study, we investigated whether the SNP rs6859 in nectin cell adhesion molecule 2 (NECTIN2) gene (a major risk factor for AD) influences trajectories of cognitive decline in older participants from the Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Methods

We retrospectively analyzed records on 1310 participants from the ADNI database for the multivariate analysis. We used longitudinal measures of Mini-Mental State Examination (MMSE) scores in participants, who were cognitively normal, or having AD, or other cognitive deficits to investigate the trajectories of cognitive changes. Multiple linear regression, linear mixed models and latent class analyses were conducted to investigate the association of the SNP rs6859 with MMSE.

Results

The regression coefficient per one allele dose of the SNP rs6859 was independently associated with MMSE in both cross-sectional (-2.23, p < 0.01) and linear mixed models (-2.26, p < 0.01) analyses. The latent class model with three distinct subgroups (class 1: stable and gradual decline, class 2: intermediate and late decline, and class 3: lowest and irregular) performed best in the posterior classification, 42.67% (n = 559), 21.45% (n = 281), 35.88% (n = 470) were classified as class 1, class 2, and class 3. In the heterogeneous linear mixed model, the regression coefficient per one allele dose of rs6859 – A risk allele was significantly associated with MMSE class 1 and class 2 memberships and related decline; Class 1 (-2.28, 95% CI: -4.05, -0.50, p < 0.05), Class 2 (-5.56, 95% CI: -9.61, -1.51, p < 0.01) and Class 3 (-0.37, 95% CI: -1.62, 0.87, p = 0.55).

Conclusions

This study found statistical evidence supporting the classification of three latent subclass groups representing complex MMSE trajectories in the ADNI cohort. The SNP rs6859 can be suggested as a candidate genetic predictor of variation in modeling MMSE trajectory, as well as for identifying latent classes with higher baseline MMSE. Functional studies may help further elucidate this relationship.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63–75. e2.PubMedCrossRef Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63–75. e2.PubMedCrossRef
3.
go back to reference Arevalo-Rodriguez I, Smailagic N, Roqué i Figuls M, Ciapponi A, Sanchez-Perez E, Giannakou A, et al. Mini-mental State Examination (MMSE) for the detection of Alzheimer’s disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2015;2015(3):CD010783.PubMedPubMedCentral Arevalo-Rodriguez I, Smailagic N, Roqué i Figuls M, Ciapponi A, Sanchez-Perez E, Giannakou A, et al. Mini-mental State Examination (MMSE) for the detection of Alzheimer’s disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2015;2015(3):CD010783.PubMedPubMedCentral
4.
5.
go back to reference Benatar M, Wuu J, McHutchison C, Postuma RB, Boeve BF, Petersen R, et al. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases. Brain. 2022;145(1):27–44.PubMedCrossRef Benatar M, Wuu J, McHutchison C, Postuma RB, Boeve BF, Petersen R, et al. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases. Brain. 2022;145(1):27–44.PubMedCrossRef
6.
go back to reference Nagaratnam JM, Sharmin S, Diker A, Lim WK, Maier AB. Trajectories of Mini-mental State Examination scores over the Lifespan in General populations: a systematic review and Meta-regression analysis. Clin Gerontol. 2022;45(3):467–76.PubMedCrossRef Nagaratnam JM, Sharmin S, Diker A, Lim WK, Maier AB. Trajectories of Mini-mental State Examination scores over the Lifespan in General populations: a systematic review and Meta-regression analysis. Clin Gerontol. 2022;45(3):467–76.PubMedCrossRef
7.
go back to reference Atri A. The Alzheimer’s Disease Clinical Spectrum: diagnosis and management. Med Clin North Am. 2019;103(2):263–93.PubMedCrossRef Atri A. The Alzheimer’s Disease Clinical Spectrum: diagnosis and management. Med Clin North Am. 2019;103(2):263–93.PubMedCrossRef
8.
go back to reference Gluhm S, Goldstein J, Loc K, Colt A, Liew C, Van, Corey-Bloom J. Cognitive performance on the mini-mental state examination and the montreal cognitive assessment across the healthy adult lifespan. Cogn Behav Neurol. 2013;26(1):1–5.PubMedPubMedCentralCrossRef Gluhm S, Goldstein J, Loc K, Colt A, Liew C, Van, Corey-Bloom J. Cognitive performance on the mini-mental state examination and the montreal cognitive assessment across the healthy adult lifespan. Cogn Behav Neurol. 2013;26(1):1–5.PubMedPubMedCentralCrossRef
9.
go back to reference Nieuwenhuis-Mark RE. The death knoll for the MMSE: has it outlived its purpose? J Geriatr Psychiatry Neurol. 2010;23(3):151–7.PubMedCrossRef Nieuwenhuis-Mark RE. The death knoll for the MMSE: has it outlived its purpose? J Geriatr Psychiatry Neurol. 2010;23(3):151–7.PubMedCrossRef
10.
go back to reference Silva MVF, Loures C, de Alves MG, de Souza LCV, Borges LC. Carvalho M Das G. Alzheimer’s disease: risk factors and potentially protective measures. J Biomed Sci. 2019;26(1):33.PubMedPubMedCentralCrossRef Silva MVF, Loures C, de Alves MG, de Souza LCV, Borges LC. Carvalho M Das G. Alzheimer’s disease: risk factors and potentially protective measures. J Biomed Sci. 2019;26(1):33.PubMedPubMedCentralCrossRef
11.
go back to reference Wang QQ, Davis PB, Gurney ME, Xu R. COVID-19 and dementia: analyses of risk, disparity, and outcomes from electronic health records in the US. Alzheimers Dement. 2021;17(8):1297–306.PubMedPubMedCentralCrossRef Wang QQ, Davis PB, Gurney ME, Xu R. COVID-19 and dementia: analyses of risk, disparity, and outcomes from electronic health records in the US. Alzheimers Dement. 2021;17(8):1297–306.PubMedPubMedCentralCrossRef
13.
go back to reference Lövheim H, Gilthorpe J, Adolfsson R, Nilsson LG, Elgh F. Reactivated herpes simplex infection increases the risk of Alzheimer’s disease. Alzheimers Dement. 2015;11(6):593–9.PubMedCrossRef Lövheim H, Gilthorpe J, Adolfsson R, Nilsson LG, Elgh F. Reactivated herpes simplex infection increases the risk of Alzheimer’s disease. Alzheimers Dement. 2015;11(6):593–9.PubMedCrossRef
14.
go back to reference Lopatko Lindman K, Hemmingsson ES, Weidung B, Brännström J, Josefsson M, Olsson J, et al. Herpesvirus infections, antiviral treatment, and the risk of dementia—a registry-based cohort study in Sweden. Alzheimers Dement. 2021;7(1):e11219. Lopatko Lindman K, Hemmingsson ES, Weidung B, Brännström J, Josefsson M, Olsson J, et al. Herpesvirus infections, antiviral treatment, and the risk of dementia—a registry-based cohort study in Sweden. Alzheimers Dement. 2021;7(1):e11219.
15.
go back to reference Ogawa H, Fujikura D, Namba H, Yamashita N, Honda T, Yamada M. Nectin-2 acts as a viral entry mediated Molecule that binds to human herpesvirus 6B glycoprotein B. Viruses. 2022;14(1):160.PubMedPubMedCentralCrossRef Ogawa H, Fujikura D, Namba H, Yamashita N, Honda T, Yamada M. Nectin-2 acts as a viral entry mediated Molecule that binds to human herpesvirus 6B glycoprotein B. Viruses. 2022;14(1):160.PubMedPubMedCentralCrossRef
16.
go back to reference Goldhardt O, Freiberger R, Dreyer T, Wilner L, Yakushev I, Ortner M, et al. Herpes simplex virus alters Alzheimer’s disease biomarkers - a hypothesis paper. Alzheimers Dement. 2023;19(5):2117–34.PubMedCrossRef Goldhardt O, Freiberger R, Dreyer T, Wilner L, Yakushev I, Ortner M, et al. Herpes simplex virus alters Alzheimer’s disease biomarkers - a hypothesis paper. Alzheimers Dement. 2023;19(5):2117–34.PubMedCrossRef
17.
go back to reference Wozniak MA, Mee AP, Itzhaki RF. Herpes simplex virus type 1 DNA is located within Alzheimer’s disease amyloid plaques. J Pathol. 2009;217(1):131–8.PubMedCrossRef Wozniak MA, Mee AP, Itzhaki RF. Herpes simplex virus type 1 DNA is located within Alzheimer’s disease amyloid plaques. J Pathol. 2009;217(1):131–8.PubMedCrossRef
18.
go back to reference Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. Herpes simplex virus type 1 in brain and risk of Alzheimer’s disease. Lancet. 1997;349(9047):241–4.PubMedCrossRef Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. Herpes simplex virus type 1 in brain and risk of Alzheimer’s disease. Lancet. 1997;349(9047):241–4.PubMedCrossRef
19.
go back to reference Yashin AI, Fang F, Kovtun M, Wu D, Duan M, Arbeev K, et al. Hidden heterogeneity in Alzheimer’s disease: insights from genetic association studies and other analyses. Exp Gerontol. 2018;107:148–60.PubMedCrossRef Yashin AI, Fang F, Kovtun M, Wu D, Duan M, Arbeev K, et al. Hidden heterogeneity in Alzheimer’s disease: insights from genetic association studies and other analyses. Exp Gerontol. 2018;107:148–60.PubMedCrossRef
20.
go back to reference Logue MW, Schu M, Vardarajan BN, Buros J, Green RC, Go RCP, et al. A Comprehensive Genetic Association Study of Alzheimer Disease in African americans. Arch Neurol. 2011;68(12):1579.CrossRef Logue MW, Schu M, Vardarajan BN, Buros J, Green RC, Go RCP, et al. A Comprehensive Genetic Association Study of Alzheimer Disease in African americans. Arch Neurol. 2011;68(12):1579.CrossRef
21.
go back to reference Mizutani K, Miyata M, Shiotani H, Kameyama T, Takai Y. Nectin-2 in general and in the brain. Mol Cell Biochem. 2022;477(1):167–80.PubMedCrossRef Mizutani K, Miyata M, Shiotani H, Kameyama T, Takai Y. Nectin-2 in general and in the brain. Mol Cell Biochem. 2022;477(1):167–80.PubMedCrossRef
22.
go back to reference Lee EG, Leong L, Chen S, Tulloch J, Yu CE. APOE Locus-Associated mitochondrial function and its implication in Alzheimer’s Disease and Aging. Int J Mol Sci. 2023;24(13):10440.PubMedPubMedCentralCrossRef Lee EG, Leong L, Chen S, Tulloch J, Yu CE. APOE Locus-Associated mitochondrial function and its implication in Alzheimer’s Disease and Aging. Int J Mol Sci. 2023;24(13):10440.PubMedPubMedCentralCrossRef
23.
go back to reference Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, et al. Alzheimer’s Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology. 2010;74(3):201–9.PubMedPubMedCentralCrossRef Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, et al. Alzheimer’s Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology. 2010;74(3):201–9.PubMedPubMedCentralCrossRef
24.
go back to reference Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J et al. 2014 Update of the Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimers Dement. 2015;11(6): e 1-120. Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J et al. 2014 Update of the Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimers Dement. 2015;11(6): e 1-120.
26.
go back to reference Chang CC, Chow CC, Tellier LCAM, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4(1): s13742-015-0047–8. Chang CC, Chow CC, Tellier LCAM, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4(1): s13742-015-0047–8.
27.
go back to reference Proust-Lima C, Dartigues JF, Jacqmin-Gadda H. Misuse of the linear mixed model when evaluating risk factors of cognitive decline. Am J Epidemiol. 2011;174(9):1077–88.PubMedCrossRef Proust-Lima C, Dartigues JF, Jacqmin-Gadda H. Misuse of the linear mixed model when evaluating risk factors of cognitive decline. Am J Epidemiol. 2011;174(9):1077–88.PubMedCrossRef
28.
go back to reference Liu Q, Wang L. t-Test and ANOVA for data with ceiling and/or floor effects. Behav Res. 2021;53(1):264–77.CrossRef Liu Q, Wang L. t-Test and ANOVA for data with ceiling and/or floor effects. Behav Res. 2021;53(1):264–77.CrossRef
29.
go back to reference Guerra-Peña K, García-Batista ZE, Depaoli S, Garrido LE. Class enumeration false positive in skew-t family of continuous growth mixture models. PLoS ONE. 2020;15(4):e0231525.PubMedPubMedCentralCrossRef Guerra-Peña K, García-Batista ZE, Depaoli S, Garrido LE. Class enumeration false positive in skew-t family of continuous growth mixture models. PLoS ONE. 2020;15(4):e0231525.PubMedPubMedCentralCrossRef
31.
go back to reference Philipps V, Amieva H, Andrieu S, Dufouil C, Berr C, Dartigues JF, et al. Normalized Mini-mental State examination for assessing Cognitive Change in Population-based brain aging studies. Neuroepidemiology. 2014;43(1):15–25.PubMedCrossRef Philipps V, Amieva H, Andrieu S, Dufouil C, Berr C, Dartigues JF, et al. Normalized Mini-mental State examination for assessing Cognitive Change in Population-based brain aging studies. Neuroepidemiology. 2014;43(1):15–25.PubMedCrossRef
34.
go back to reference VanderWeele TJ, Ding P. Sensitivity analysis in Observational Research: introducing the E-Value. Ann Intern Med. 2017;167(4):268–74.PubMedCrossRef VanderWeele TJ, Ding P. Sensitivity analysis in Observational Research: introducing the E-Value. Ann Intern Med. 2017;167(4):268–74.PubMedCrossRef
35.
go back to reference Bates D, Mächler M, Bolker B, Walker S. Fitting Linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1–48.CrossRef Bates D, Mächler M, Bolker B, Walker S. Fitting Linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1–48.CrossRef
36.
go back to reference Ozaki Y, Yano M, Onishi M. Effective hyperparameter optimization using nelder-mead method in deep learning. IPSJ T Comput Vis Appl. 2017;9:20.CrossRef Ozaki Y, Yano M, Onishi M. Effective hyperparameter optimization using nelder-mead method in deep learning. IPSJ T Comput Vis Appl. 2017;9:20.CrossRef
37.
go back to reference Lai J, Zou Y, Zhang S, Zhang X, Mao L, Zhang WH. glmm.hp: an R package for computing individual effect of predictors in generalized linear mixed models. J Plant Ecol. 2022;15(6):1302–7.CrossRef Lai J, Zou Y, Zhang S, Zhang X, Mao L, Zhang WH. glmm.hp: an R package for computing individual effect of predictors in generalized linear mixed models. J Plant Ecol. 2022;15(6):1302–7.CrossRef
38.
go back to reference Vermunt JK, Magidson J. Latent class models for classiÿcation. Comput Stat Data Anal. 2003;41:531–7.CrossRef Vermunt JK, Magidson J. Latent class models for classiÿcation. Comput Stat Data Anal. 2003;41:531–7.CrossRef
39.
go back to reference Linzer DA, Lewis JB. poLCA: an R Package for Polytomous Variable Latent Class Analysis. J Stat Softw. 2011;42(10):1–29.CrossRef Linzer DA, Lewis JB. poLCA: an R Package for Polytomous Variable Latent Class Analysis. J Stat Softw. 2011;42(10):1–29.CrossRef
40.
go back to reference Proust-Lima C, Philipps V, Liquet B. Estimation of extended mixed models using latent classes and latent processes: the R package lcmm. J Stat Softw. 2017;78(2):1–56.CrossRef Proust-Lima C, Philipps V, Liquet B. Estimation of extended mixed models using latent classes and latent processes: the R package lcmm. J Stat Softw. 2017;78(2):1–56.CrossRef
41.
go back to reference Xiao Q, Xi J, Wang R, Zhao Q, Liang X, Wu W, et al. The relationship between low-density lipoprotein cholesterol and progression of mild cognitive impairment: the influence of rs6859 in PVRL2. Front Genet. 2022;13:823406.PubMedPubMedCentralCrossRef Xiao Q, Xi J, Wang R, Zhao Q, Liang X, Wu W, et al. The relationship between low-density lipoprotein cholesterol and progression of mild cognitive impairment: the influence of rs6859 in PVRL2. Front Genet. 2022;13:823406.PubMedPubMedCentralCrossRef
42.
go back to reference Ukraintseva S, Duan M, Simanek AM, Holmes R, Bagley O, Rajendrakumar AL, et al. Vaccination against Pneumonia May provide genotype-specific Protection Against Alzheimer’s Disease. J Alzheimers Dis. 2023;96(2):499–505.PubMedPubMedCentralCrossRef Ukraintseva S, Duan M, Simanek AM, Holmes R, Bagley O, Rajendrakumar AL, et al. Vaccination against Pneumonia May provide genotype-specific Protection Against Alzheimer’s Disease. J Alzheimers Dis. 2023;96(2):499–505.PubMedPubMedCentralCrossRef
43.
go back to reference Fiocco AJ, Yaffe K. Defining successful aging: the importance of including cognitive function over Time. Arch Neurol. 2010;67(7):876–80.PubMedCrossRef Fiocco AJ, Yaffe K. Defining successful aging: the importance of including cognitive function over Time. Arch Neurol. 2010;67(7):876–80.PubMedCrossRef
44.
go back to reference Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992;40(9):922–35.PubMedCrossRef Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992;40(9):922–35.PubMedCrossRef
45.
go back to reference Koga H, Yuzuriha T, Yao H, Endo K, Hiejima S, Takashima Y, et al. Quantitative MRI findings and cognitive impairment among community dwelling elderly subjects. J Neurol Neurosurg Psychiatry. 2002;72(6):737–41.PubMedPubMedCentralCrossRef Koga H, Yuzuriha T, Yao H, Endo K, Hiejima S, Takashima Y, et al. Quantitative MRI findings and cognitive impairment among community dwelling elderly subjects. J Neurol Neurosurg Psychiatry. 2002;72(6):737–41.PubMedPubMedCentralCrossRef
46.
go back to reference Coulombe J, Moodie EEM, Shortreed SM, Renoux C. Estimating individualized treatment rules in longitudinal studies with covariate-driven observation times. Stat Methods Med Res. 2023;32(5):868–84.MathSciNetPubMedPubMedCentralCrossRef Coulombe J, Moodie EEM, Shortreed SM, Renoux C. Estimating individualized treatment rules in longitudinal studies with covariate-driven observation times. Stat Methods Med Res. 2023;32(5):868–84.MathSciNetPubMedPubMedCentralCrossRef
47.
go back to reference Morris MC, Evans DA, Hebert LE, Bienias JL. Methodological issues in the study of Cognitive decline. Am J Epidemiol. 1999;149(9):789–93.PubMedCrossRef Morris MC, Evans DA, Hebert LE, Bienias JL. Methodological issues in the study of Cognitive decline. Am J Epidemiol. 1999;149(9):789–93.PubMedCrossRef
48.
go back to reference Chen M, Hu C. A history of cigarette smoking is associated with faster functional decline and reduction of entorhinal cortex volume in mild cognitive impairment. Aging (Albany NY). 2021;13(4):6205–13.PubMedCrossRef Chen M, Hu C. A history of cigarette smoking is associated with faster functional decline and reduction of entorhinal cortex volume in mild cognitive impairment. Aging (Albany NY). 2021;13(4):6205–13.PubMedCrossRef
49.
go back to reference Bauco C, Borriello C, Cinti AM, Martella S, Zannino G, Rossetti C, et al. Correlation between MMSE performance, age and education in centenarians. Arch Gerontol Geriatr. 1998;26(1):23–6.CrossRef Bauco C, Borriello C, Cinti AM, Martella S, Zannino G, Rossetti C, et al. Correlation between MMSE performance, age and education in centenarians. Arch Gerontol Geriatr. 1998;26(1):23–6.CrossRef
50.
go back to reference Skirbekk V, Bowen CE, Håberg A, Jugessur A, Engdahl B, Bratsberg B, et al. Marital histories and associations with later-life dementia and mild cognitive impairment risk in the HUNT4 70 + study in Norway. J Aging Health. 2022;35(7–8):543–55.PubMedPubMedCentral Skirbekk V, Bowen CE, Håberg A, Jugessur A, Engdahl B, Bratsberg B, et al. Marital histories and associations with later-life dementia and mild cognitive impairment risk in the HUNT4 70 + study in Norway. J Aging Health. 2022;35(7–8):543–55.PubMedPubMedCentral
51.
go back to reference Duarte-Guterman P, Albert AY, Barha CK, Galea LAM, on behalf of the Alzheimer’s Disease Neuroimaging Initiative. Sex influences the effects of APOE genotype and Alzheimer’s diagnosis on neuropathology and memory. Psychoneuroendocrinology. 2021;129:105248.PubMedCrossRef Duarte-Guterman P, Albert AY, Barha CK, Galea LAM, on behalf of the Alzheimer’s Disease Neuroimaging Initiative. Sex influences the effects of APOE genotype and Alzheimer’s diagnosis on neuropathology and memory. Psychoneuroendocrinology. 2021;129:105248.PubMedCrossRef
52.
go back to reference Ge XY, Cui K, Liu L, Qin Y, Cui J, Han HJ, et al. Screening and predicting progression from high-risk mild cognitive impairment to Alzheimer’s disease. Sci Rep. 2021;11(1):17558.ADSPubMedPubMedCentralCrossRef Ge XY, Cui K, Liu L, Qin Y, Cui J, Han HJ, et al. Screening and predicting progression from high-risk mild cognitive impairment to Alzheimer’s disease. Sci Rep. 2021;11(1):17558.ADSPubMedPubMedCentralCrossRef
53.
go back to reference Scuteri A, Coluccia R, Castello L, Nevola E, Brancati AM, Volpe M. Left ventricular mass increase is associated with cognitive decline and dementia in the elderly independently of blood pressure. Eur Heart J. 2009;30(12):1525–9.PubMedCrossRef Scuteri A, Coluccia R, Castello L, Nevola E, Brancati AM, Volpe M. Left ventricular mass increase is associated with cognitive decline and dementia in the elderly independently of blood pressure. Eur Heart J. 2009;30(12):1525–9.PubMedCrossRef
54.
go back to reference Nguyen TT, Ta QTH, Nguyen TKO, Nguyen TTD, Giau V, Van. Type 3 diabetes and its role implications in Alzheimer’s disease. Int J Mol Sci. 2020;21(9):3165.PubMedPubMedCentralCrossRef Nguyen TT, Ta QTH, Nguyen TKO, Nguyen TTD, Giau V, Van. Type 3 diabetes and its role implications in Alzheimer’s disease. Int J Mol Sci. 2020;21(9):3165.PubMedPubMedCentralCrossRef
55.
go back to reference Scuteri A, Benetos A, Sierra C, Coca A, Chicherio C, Frisoni GB, et al. Routine assessment of cognitive function in older patients with hypertension seen by primary care physicians: why and how—a decision-making support from the working group on ‘hypertension and the brain’ of the European Society of Hypertension and from the European Geriatric Medicine Society. J Hypertens. 2021;39(1):90–100.PubMedCrossRef Scuteri A, Benetos A, Sierra C, Coca A, Chicherio C, Frisoni GB, et al. Routine assessment of cognitive function in older patients with hypertension seen by primary care physicians: why and how—a decision-making support from the working group on ‘hypertension and the brain’ of the European Society of Hypertension and from the European Geriatric Medicine Society. J Hypertens. 2021;39(1):90–100.PubMedCrossRef
56.
go back to reference Guardiola M, Muntané G, Martínez I, Martorell L, Girona J, Ibarretxe D, et al. Metabolic overlap between Alzheimer’s Disease and metabolic syndrome identifies the PVRL2 gene as a New Modulator of Diabetic Dyslipidemia. Int J Mol Sci. 2023;24(8):7415.PubMedPubMedCentralCrossRef Guardiola M, Muntané G, Martínez I, Martorell L, Girona J, Ibarretxe D, et al. Metabolic overlap between Alzheimer’s Disease and metabolic syndrome identifies the PVRL2 gene as a New Modulator of Diabetic Dyslipidemia. Int J Mol Sci. 2023;24(8):7415.PubMedPubMedCentralCrossRef
57.
go back to reference Satomi-Kobayashi S, Ueyama T, Mueller S, Toh R, Masano T, Sakoda T, et al. Deficiency of nectin-2 leads to cardiac fibrosis and dysfunction under chronic pressure overload. Hypertension. 2009;54:825–31.PubMedCrossRef Satomi-Kobayashi S, Ueyama T, Mueller S, Toh R, Masano T, Sakoda T, et al. Deficiency of nectin-2 leads to cardiac fibrosis and dysfunction under chronic pressure overload. Hypertension. 2009;54:825–31.PubMedCrossRef
58.
go back to reference Michailidis M, Tata DA, Moraitou D, Kavvadas D, Karachrysafi S, Papamitsou T, et al. Antidiabetic drugs in the treatment of Alzheimer’s Disease. Int J Mol Sci. 2022;23(9):4641.PubMedPubMedCentralCrossRef Michailidis M, Tata DA, Moraitou D, Kavvadas D, Karachrysafi S, Papamitsou T, et al. Antidiabetic drugs in the treatment of Alzheimer’s Disease. Int J Mol Sci. 2022;23(9):4641.PubMedPubMedCentralCrossRef
59.
go back to reference Miyata M, Mandai K, Maruo T, Sato J, Shiotani H, Kaito A, et al. Localization of nectin-2δ at perivascular astrocytic endfoot processes and degeneration of astrocytes and neurons in nectin-2 knockout mouse brain. Brain Res. 2016;1649(Pt A):90–101.PubMedCrossRef Miyata M, Mandai K, Maruo T, Sato J, Shiotani H, Kaito A, et al. Localization of nectin-2δ at perivascular astrocytic endfoot processes and degeneration of astrocytes and neurons in nectin-2 knockout mouse brain. Brain Res. 2016;1649(Pt A):90–101.PubMedCrossRef
60.
go back to reference Liu E, Dyer SM, O’Donnell LK, Milte R, Bradley C, Harrison SL, et al. Association of cardiovascular system medications with cognitive function and dementia in older adults living in nursing homes in Australia. J Geriatr Cardiol. 2017;14(6):407–15.PubMedPubMedCentral Liu E, Dyer SM, O’Donnell LK, Milte R, Bradley C, Harrison SL, et al. Association of cardiovascular system medications with cognitive function and dementia in older adults living in nursing homes in Australia. J Geriatr Cardiol. 2017;14(6):407–15.PubMedPubMedCentral
61.
go back to reference Schmader KE, Hanlon IJT, Fillenbaum GG, Huber MI, Pieper C, Horner RI. Medication use patterns among demented, cognitively impaired and cognitively intact community-dwelling elderly people. Age Ageing. 1998;27(4):493–501.PubMedCrossRef Schmader KE, Hanlon IJT, Fillenbaum GG, Huber MI, Pieper C, Horner RI. Medication use patterns among demented, cognitively impaired and cognitively intact community-dwelling elderly people. Age Ageing. 1998;27(4):493–501.PubMedCrossRef
62.
go back to reference Cermakova P, Fereshtehnejad SM, Johnell K, Winblad B, Eriksdotter M, Religa D. Cardiovascular medication burden in dementia disorders: a nationwide study of 19,743 dementia patients in the Swedish Dementia Registry. Alzheimers Res Ther. 2014;6(3):34.PubMedPubMedCentralCrossRef Cermakova P, Fereshtehnejad SM, Johnell K, Winblad B, Eriksdotter M, Religa D. Cardiovascular medication burden in dementia disorders: a nationwide study of 19,743 dementia patients in the Swedish Dementia Registry. Alzheimers Res Ther. 2014;6(3):34.PubMedPubMedCentralCrossRef
63.
go back to reference Xie H, Mayo N, Koski L. Identifying and characterizing trajectories of cognitive change in older persons with mild cognitive impairment. Dement Geriatr Cogn Disord. 2011;31(2):165–72.PubMedCrossRef Xie H, Mayo N, Koski L. Identifying and characterizing trajectories of cognitive change in older persons with mild cognitive impairment. Dement Geriatr Cogn Disord. 2011;31(2):165–72.PubMedCrossRef
64.
go back to reference Gharbi-Meliani A, Dugravot A, Sabia S, Regy M, Fayosse A, Schnitzler A, et al. The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study. Alz Res Therapy. 2021;13(1):5.CrossRef Gharbi-Meliani A, Dugravot A, Sabia S, Regy M, Fayosse A, Schnitzler A, et al. The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study. Alz Res Therapy. 2021;13(1):5.CrossRef
65.
go back to reference Caselli RJ, Dueck AC, Osborne D, Sabbagh MN, Connor DJ, Ahern GL, et al. Longitudinal modeling of Age-Related memory decline and the APOE ε4 effect. N Engl J Med. 2009;361(3):255–63.PubMedPubMedCentralCrossRef Caselli RJ, Dueck AC, Osborne D, Sabbagh MN, Connor DJ, Ahern GL, et al. Longitudinal modeling of Age-Related memory decline and the APOE ε4 effect. N Engl J Med. 2009;361(3):255–63.PubMedPubMedCentralCrossRef
66.
go back to reference Lobo E, Gracia-García P, Lobo A, Saz P, De-La-cámara C. Differences in trajectories and predictive factors of cognition over time in a sample of cognitively healthy adults, in Zaragoza, Spain. Int J Environ Res Public Health. 2021;18(13):7092.PubMedPubMedCentralCrossRef Lobo E, Gracia-García P, Lobo A, Saz P, De-La-cámara C. Differences in trajectories and predictive factors of cognition over time in a sample of cognitively healthy adults, in Zaragoza, Spain. Int J Environ Res Public Health. 2021;18(13):7092.PubMedPubMedCentralCrossRef
67.
go back to reference Min JW. A longitudinal study of cognitive trajectories and its factors for koreans aged 60 and over: a latent growth mixture model. Int J Geriatr Psychiatry. 2018;33(5):755–62.PubMedCrossRef Min JW. A longitudinal study of cognitive trajectories and its factors for koreans aged 60 and over: a latent growth mixture model. Int J Geriatr Psychiatry. 2018;33(5):755–62.PubMedCrossRef
68.
go back to reference Yu W, Chen R, Zhang M, Li Z, Gao F, Yu S, et al. Cognitive decline trajectories and influencing factors in China: a non-normal growth mixture model analysis. Arch Gerontol Geriatr. 2021;95:104381.PubMedCrossRef Yu W, Chen R, Zhang M, Li Z, Gao F, Yu S, et al. Cognitive decline trajectories and influencing factors in China: a non-normal growth mixture model analysis. Arch Gerontol Geriatr. 2021;95:104381.PubMedCrossRef
69.
go back to reference Wilkosz PA, Seltman HJ, Devlin B, Weamer EA, Lopez OL, Dekosky ST, et al. Trajectories of cognitive decline in Alzheimer’s disease. Int Psychogeriatr. 2010;22(2):281–90.PubMedCrossRef Wilkosz PA, Seltman HJ, Devlin B, Weamer EA, Lopez OL, Dekosky ST, et al. Trajectories of cognitive decline in Alzheimer’s disease. Int Psychogeriatr. 2010;22(2):281–90.PubMedCrossRef
70.
go back to reference Cohen CI, Reisberg B, Yaffee R. Global cognitive trajectory patterns in Alzheimer’s disease. Int Psychogeriatr. 2022;1–10. Cohen CI, Reisberg B, Yaffee R. Global cognitive trajectory patterns in Alzheimer’s disease. Int Psychogeriatr. 2022;1–10.
71.
go back to reference Wu Z, Phyo AZZ, Al-harbi T, Woods RL, Ryan J. Distinct cognitive trajectories in Late Life and Associated predictors and outcomes: a systematic review. J Alzheimers Dis Rep. 2020;4(1):459–78.PubMedPubMedCentralCrossRef Wu Z, Phyo AZZ, Al-harbi T, Woods RL, Ryan J. Distinct cognitive trajectories in Late Life and Associated predictors and outcomes: a systematic review. J Alzheimers Dis Rep. 2020;4(1):459–78.PubMedPubMedCentralCrossRef
72.
go back to reference Moustafa AA, Tindle R, Alashwal H, Diallo TMO. A longitudinal study using latent curve models of groups with mild cognitive impairment and Alzheimer’s disease. J Neurosci Methods. 2021;350:109040.PubMedCrossRef Moustafa AA, Tindle R, Alashwal H, Diallo TMO. A longitudinal study using latent curve models of groups with mild cognitive impairment and Alzheimer’s disease. J Neurosci Methods. 2021;350:109040.PubMedCrossRef
73.
go back to reference Huang SY, Yang YX, Kuo K, Li HQ, Shen XN, Chen SD, et al. Herpesvirus infections and Alzheimer’s disease: a mendelian randomization study. Alz Res Therapy. 2021;13(1):158.CrossRef Huang SY, Yang YX, Kuo K, Li HQ, Shen XN, Chen SD, et al. Herpesvirus infections and Alzheimer’s disease: a mendelian randomization study. Alz Res Therapy. 2021;13(1):158.CrossRef
74.
go back to reference Mizutani K, Miyata M, Shiotani H, Kameyama T, Takai Y. Nectins and nectin-like molecules in synapse formation and involvement in neurological diseases. Mol Cell Neurosci. 2021;115:103653.PubMedCrossRef Mizutani K, Miyata M, Shiotani H, Kameyama T, Takai Y. Nectins and nectin-like molecules in synapse formation and involvement in neurological diseases. Mol Cell Neurosci. 2021;115:103653.PubMedCrossRef
76.
go back to reference Lu F, Guan H, Gong B, Liu X, Zhu R, Wang Y, et al. Genetic variants in PVRL2-TOMM40-APOE region are Associated with Human Longevity in a Han Chinese Population. PLoS ONE. 2014;9(6):e99580.ADSPubMedPubMedCentralCrossRef Lu F, Guan H, Gong B, Liu X, Zhu R, Wang Y, et al. Genetic variants in PVRL2-TOMM40-APOE region are Associated with Human Longevity in a Han Chinese Population. PLoS ONE. 2014;9(6):e99580.ADSPubMedPubMedCentralCrossRef
77.
go back to reference Driscoll I, Snively BM, Espeland MA, Shumaker SA, Rapp SR, Goveas JS, et al. A candidate gene study of risk for dementia in older, post-menopausal women: results from the women’s Health Initiative Memory Study. Int J Geriatr Psychiatry. 2019;34(5):692–99.PubMedCrossRef Driscoll I, Snively BM, Espeland MA, Shumaker SA, Rapp SR, Goveas JS, et al. A candidate gene study of risk for dementia in older, post-menopausal women: results from the women’s Health Initiative Memory Study. Int J Geriatr Psychiatry. 2019;34(5):692–99.PubMedCrossRef
78.
go back to reference Proust C, Jacqmin-Gadda H, Taylor JMG, Ganiayre J, Commenges D. A nonlinear model with latent process for cognitive evolution using multivariate longitudinal data. Biometrics. 2006;62(4):1014–24.MathSciNetPubMedPubMedCentralCrossRef Proust C, Jacqmin-Gadda H, Taylor JMG, Ganiayre J, Commenges D. A nonlinear model with latent process for cognitive evolution using multivariate longitudinal data. Biometrics. 2006;62(4):1014–24.MathSciNetPubMedPubMedCentralCrossRef
79.
go back to reference Espino DV, Lichtenstein MJ, Palmer RF, Hazuda HP. Ethnic differences in Mini-mental State Examination (MMSE) scores: where you live makes a difference. JAGS. 2001;49(5):538–48.CrossRef Espino DV, Lichtenstein MJ, Palmer RF, Hazuda HP. Ethnic differences in Mini-mental State Examination (MMSE) scores: where you live makes a difference. JAGS. 2001;49(5):538–48.CrossRef
80.
go back to reference Zhao L, Han C, Zheng Z, Xiu SL, Chan P. Risk of mini-mental state examination (MMSE) decline in the elderly with type 2 diabetes: a Chinese community-based cohort study. BMC Endocr Disord. 2020;20(1):129.PubMedPubMedCentralCrossRef Zhao L, Han C, Zheng Z, Xiu SL, Chan P. Risk of mini-mental state examination (MMSE) decline in the elderly with type 2 diabetes: a Chinese community-based cohort study. BMC Endocr Disord. 2020;20(1):129.PubMedPubMedCentralCrossRef
81.
go back to reference Reas ET, Laughlin GA, Bergstrom J, Kritz-Silverstein D, McEvoy LK. Physical activity and trajectories of Cognitive Change in Community-Dwelling older adults: the Rancho Bernardo Study. J Alzheimers Dis. 2019;71(1):109–18.PubMedPubMedCentralCrossRef Reas ET, Laughlin GA, Bergstrom J, Kritz-Silverstein D, McEvoy LK. Physical activity and trajectories of Cognitive Change in Community-Dwelling older adults: the Rancho Bernardo Study. J Alzheimers Dis. 2019;71(1):109–18.PubMedPubMedCentralCrossRef
Metadata
Title
The SNP rs6859 in NECTIN2 gene is associated with underlying heterogeneous trajectories of cognitive changes in older adults
Authors
Aravind Lathika Rajendrakumar
Konstantin G. Arbeev
Olivia Bagley
Anatoliy I. Yashin
Svetlana Ukraintseva
for the Alzheimer’s Disease Neuroimaging Initiative
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2024
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-024-03577-4

Other articles of this Issue 1/2024

BMC Neurology 1/2024 Go to the issue